PHARM-AD
The computed 12-month bankruptcy probability of PHARM-AD is 0.3% (very low). The company has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 16 yrs |
| Board | 2 |
| Locations | 1 |
| Publications | 2 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 30-06-2025 | micro | 30-01-2026 | 2026-00020843 |
| 30-06-2024 | micro | 30-01-2025 | 2025-00024607 |
| 30-06-2023 | micro | 24-01-2024 | 2024-00008045 |
| 30-06-2022 | micro | 30-12-2022 | 2022-20549748 |
| 30-06-2021 | micro | 24-01-2022 | 2022-01500277 |
| 30-06-2020 | micro | 21-01-2021 | 2021-01300187 |
| 30-06-2019 | micro | 24-01-2020 | 2020-02100088 |
| 30-06-2018 | micro | 11-01-2019 | 2019-01100103 |
| 30-06-2017 | micro | 14-12-2017 | 2017-71800486 |
| 30-06-2016 | volledig | 12-12-2016 | 2016-69900047 |
-
Current09-01-2024 → present
-
Current09-01-2024 → present
| NACE primary | Overige zakelijke dienstverlening, neg(82990) |
| Legal form | Private limited company(610) |
| Incorporation | 03-10-2009 |
| Status | Active |
| Postal code | 1370 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25085D0247/00E000 | Wallonia | 939 m² | 1 · 150 m² | 9.8 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
13-05-2026 Notarial deed · General meeting · Statute amendment · First fiscal year
- Filing: 2026-05-11 · PHARM-AD
- Publication: 2026-05-13 · PHARM-AD
- Notarial deed: 2026-05-04 · PHARM-AD
- General meeting: date: 2026-05-04, type: extraordinaire · PHARM-AD
- Statute amendment: content: Modification de l'exercice social et de la date de l'assemblée générale ordinaire · PHARM-AD
- First fiscal year: end: 2026-12-31, start: 2026-01-01 · PHARM-AD
- Accounting effect: end: 2026-12-31, start: 2025-07-01 · PHARM-AD
- Annual meeting schedule: schedule: premier vendredi du mois de mai, à 17h00 au siège · PHARM-AD
- Power of attorney: date: 2026-05-04, purpose: faire le nécessaire auprès du guichet d’entreprise pour porter à leur connaissance et au notaire soussigné pour la coordination des statuts, granted_to: chacun des administrateurs · PHARM-AD
- Act object: ANNEE COMPTABLE, ASSEMBLEE GENERALE
Technical details
{
"facts": [
{
"type": "filing",
"quote": "D\u00E9pos\u00E9 11-05-2026",
"value": "2026-05-11",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 13/05/2026 - Annexes du Moniteur belge",
"value": "2026-05-13",
"object": null,
"subject": "e1"
},
{
"type": "notarial_deed",
"quote": "Il r\u00E9sulte d\u2019un proc\u00E8s-verbal dress\u00E9 par le notaire Thibaut van DOORSLAER de ten RYEN, notaire associ\u00E9 \u00E0 Jodoigne, en date du 4 mai 2026",
"value": "2026-05-04",
"object": "e2",
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "l\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire des actionnaires de la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB PHARM-AD\u00BB ... en date du 4 mai 2026",
"value": {
"date": "2026-05-04",
"type": "extraordinaire"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de remplacer \u2022 L\u2019article 17 premier alin\u00E9a par le texte suivant ... \u2022 l\u0027article 22 des statuts par le texte suivant",
"value": {
"content": "Modification de l\u0027exercice social et de la date de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire",
"articles": [
"17",
"22"
]
},
"object": null,
"subject": "e1"
},
{
"type": "first_fiscal_year",
"quote": "L\u2019exercice social commence le 1er janvier et se termine le 31 d\u00E9cembre de chaque ann\u00E9e.",
"value": {
"end": "2026-12-31",
"start": "2026-01-01"
},
"object": null,
"subject": "e1"
},
{
"type": "accounting_effect",
"quote": "l\u2019exercice social en cours, ayant pris cours le 1er juillet 2025 se cl\u00F4turera le 31 d\u00E9cembre 2026.",
"value": {
"end": "2026-12-31",
"start": "2025-07-01"
},
"object": null,
"subject": "e1"
},
{
"type": "annual_meeting_schedule",
"quote": "La date de l\u2019assembl\u00E9e g\u00E9n\u00E9rale ordinaire est en cons\u00E9quence d\u00E9sormais fix\u00E9e au premier vendredi du mois de mai, \u00E0 17h00 au si\u00E8ge.",
"value": {
"schedule": "premier vendredi du mois de mai, \u00E0 17h00 au si\u00E8ge"
},
"object": null,
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "L\u2019assembl\u00E9e donne tous pouvoirs \u00E0 chacun des administrateurs, avec facult\u00E9 de substitution, pour faire le n\u00E9cessaire aupr\u00E8s du guichet d\u2019entreprise pour porter \u00E0 leur connaissance et au notaire soussign\u00E9 pour la coordination des statuts.",
"value": {
"date": "2026-05-04",
"purpose": "faire le n\u00E9cessaire aupr\u00E8s du guichet d\u2019entreprise pour porter \u00E0 leur connaissance et au notaire soussign\u00E9 pour la coordination des statuts",
"granted_to": "chacun des administrateurs"
},
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte : ANNEE COMPTABLE, ASSEMBLEE GENERALE",
"value": "ANNEE COMPTABLE, ASSEMBLEE GENERALE",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 3208,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0819.236.165",
"kind": "company",
"name": "PHARM-AD",
"attrs": {
"seat": "Rue Sainte-Gertrude(Pi\u00E9t.) 5, 1370 Jodoigne-Souveraine",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Thibaut van DOORSLAER de ten RYEN",
"attrs": {
"role": "notaire"
}
}
]
}09-01-2024 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2024-01-04",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0819.236.165",
"name_full": "PHARM-AD",
"legal_form": "SPRL"
},
"signature_regime": "solo",
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | PHARM-AD |